APR 25, 2020 7:33 AM PDT

Researchers Trial Cannabis to Treat COVID-19

WRITTEN BY: Annie Lennon

Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So far, researchers in the country are investigating three treatment candidates. 

The first is by InnoCan Pharma’s Israel-based subsidiary InnoCan Pharma Ltd. of Herzliya. In collaboration with Tel Aviv University, they are creating a treatment for COVID-19 from cannabidiol (CBD) loaded exosomes, small structures attached to cells responsible for cell-to-cell communication and the delivery of macromolecules between cells. It is hoped that the anti-inflammatory effects of CBD may be able to aid in the recovery of infected lungs. 

During their study, the researchers will use their treatment against a variety of lung infections. Throughout, the CBD-loaded exosomes will be delivered to patients via an inhalation technique. The treatment comes after animal tests showing that CBD is able to reduce bodily inflammation. It has not yet been proven however to prevent and ease illness caused by COVID-19 or other respiratory viruses. 

Another study will combine CBD with steroids as a treatment for those with COVID-19. Over the course of a few weeks, researchers aim to trial the treatment on 10 patients with COVID-19 currently receiving steroid medication at Israel’s Rabin Medical Center. If the drug combination is successful, they say that the treatment option will be expanded to another 40 patients with COVID-19 under conditions set by FDA clinical trial regulations and guidelines. 

In a press release, they said, “steroid treatment is usually the first or second line of treatment of hospitalized patients. CBD enhances the therapeutic effect of steroid treatment and treats the bio-mechanism affected by the virus.”

Meanwhile, the third study is led by Tel Aviv’s Ichilov Medical Center to understand whether cannabis’s anti-inflammatory properties may be used to slow down lung infections in those diagnosed with COVID-19. Trials of CBD-based treatments are being conducted in collaboration with several wards in the hospital. The researchers expect dozens of patients with moderate illness from COVID-19 to participate. 

Dr Barak Cohen, one of the researchers behind the study says, ““this is a novel approach to treating some of the symptoms, using a component of the cannabis plant that is considered safe and non-addictive.”

 

Sources: Jewish Press, the Legal Examiner, Yahoo Finance, The Cannigma

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JAN 12, 2020
Cannabis Sciences
JAN 12, 2020
Scientists Discover Cannabinoid 30 Times Stronger than THC
Scientists from Italy have identified a new cannabinoid in the glands of the Cannabis plant, known as tetrahydrocannabin ...
FEB 05, 2020
Cannabis Sciences
FEB 05, 2020
Should You Be Using Marijuana While Pregnant? Researchers Weigh In
Recreational marijuana use becomes increasingly common as legalization spreads across the country. That includes women w ...
APR 03, 2020
Cannabis Sciences
APR 03, 2020
Nope, Marijuana Does Not Cure COVID-19
As the COVID-19 pandemic has fueled panic across the world amid global lockdowns and spiking death tolls, some have star ...
APR 05, 2020
Cannabis Sciences
APR 05, 2020
Rats Develop Drug-Seeking Behavior After Cannabis Withdrawal
A recent study from Washington State University has found that rats with regular access to cannabis tend to show drug-se ...
APR 23, 2020
Cannabis Sciences
APR 23, 2020
No Difference Between Indica and Sativa Cannabis Strains
Cannabis growers and sellers have defined different strains of cannabis as ‘indica’ or ‘sativa’ ...
APR 24, 2020
Health & Medicine
APR 24, 2020
Study Shows Marijuana Withdrawal is Real
Whether or not an addiction to marijuana is a risk of the drug has been widely debated, with the general population typi ...
Loading Comments...